What is Radnoti?
Specializing in advanced glassware apparatus technology for over 35 years, Radnoti provides critical tools for researchers and laboratories. Their product portfolio includes organ perfusion systems, isolated heart systems, and tissue bath systems, all engineered for flexibility and customization. These offerings are crucial for studies involving cardiac and muscle tissue, underscoring Radnoti's role in facilitating cutting-edge physiological research. The company's integration into ADInstruments further solidifies its market presence and access to broader research communities.
How much funding has Radnoti raised?
Radnoti has raised a total of $96K across 1 funding round:
Debt
$96K
Debt (2021): $96K with participation from PPP
Key Investors in Radnoti
PPP
Public-Private Partnership
What's next for Radnoti?
With the recent influx of expansion capital, Radnoti is poised to enhance its product development and market reach. The significant Series B/C stage funding suggests a strategic focus on scaling operations, potentially through increased manufacturing capacity, broader distribution channels, or further innovation in its specialized apparatus. This investment will likely enable Radnoti to deepen its impact in cardiac and muscle tissue research, supporting the evolving needs of scientific inquiry and laboratory applications.
See full Radnoti company page
